Body Composition Analysis in Cirrhotic Undergoing Paracentesis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-12-31

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ascites is a frequent complication of liver cirrhosis, initial treatment consists on diuretics intake, however, as the disease progresses this complication becomes more severe, consequently other therapeutic options are used.

Paracentesis is indicated when severe ascites is present and it should be accompanied by albumin infusion.

Nutritional status is generally affected in patients with liver cirrhosis, even more patients with severe ascites show decreased energy intake due to gastric compression.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.

NCT02467322

Decompensated Cirrhosis

COMPLETED NA

Vector Analysis of Body Composition in Hospitalized Cirrhotic Patients

NCT02017301

Infection

UNKNOWN

The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study

NCT01091233

Critically Ill Liver Cirrhosis Ascites

WITHDRAWN

Lean Mass Evaluation of Cirrhotic Patients With Ascites With the Use DXA

NCT02421848

Liver Cirrhosis

COMPLETED

Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure.

NCT02467348

Acute on Chronic Liver Failure

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Cirrhosis Ascites

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Body composition in paracentesis

Taking blood samples and bioelectrical impedance, Psychometric Hepatic Encephalopathy Score (PHES) and Critical Flicker Frequency (CFF) before and after paracentesis.

Body composition in paracentesis

Intervention Type BEHAVIORAL

Takin blood samples and bioelectrical impedance measurmeent, Neuropsychological tests evaluation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Body composition in paracentesis

Takin blood samples and bioelectrical impedance measurmeent, Neuropsychological tests evaluation

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any genre.
* Age 18-70 years old.
* Diagnosis of liver cirrhosis of any etiology (documented by clinical, biochemical, radiological and / or biopsy.
* Presence of high volume ascites
* The signing of informed consent will be required for the inclusion of any patient.

Exclusion Criteria

* Hepatic encephalopathy grade III or IV. 2) liver transplantation.
* Congestive heart failure.
* Hemodialysis.
* Acute or chronic renal failure.
* Nephrotic syndrome with protein loss.
* Alcoholism active in the last 6 months.
* Pregnancy.
* upper gastrointestinal bleeding.

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No